• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Endocrinol Metab . Duodenal mucosal expression of COVID-19-related genes in health, diabetes gastroenteropathy and functional dyspepsia

tetano

Editor, Senior Moderator
J Clin Endocrinol Metab


. 2022 Jan 28;dgac038.
doi: 10.1210/clinem/dgac038. Online ahead of print.
Duodenal mucosal expression of COVID-19-related genes in health, diabetes gastroenteropathy and functional dyspepsia


Brototo Deb[SUP] 1 [/SUP], Daniel R O'Brien[SUP] 2 [/SUP], Adil E Bharucha[SUP] 1 [/SUP]



Affiliations

Abstract

Context: SARS-CoV-2 infects the gastrointestinal tract and may be associated with symptoms that resemble diabetic gastroparesis. Why patients with diabetes who contract COVID-19 are more likely to have severe disease is unknown.
Objectives: To compare the duodenal mucosal expression of SARS-CoV-2 and inflammation-related genes in healthy controls, diabetes gastroenteropathy (DGE), and functional dyspepsia (FD).
Design: Gastrointestinal transit, and duodenal mucosal mRNA expression of selected genes were compared in 21 controls, 39 DGE patients, and 37 FD patients. Pathway analyses were performed.
Setting: Tertiary referral center.
Results: Patients had normal, delayed (5 FD [13%] and 13 DGE patients [33%], P=.03 vs controls), or rapid (5 FD[12%] and 5 DGE patients[12%]) gastric emptying. Compared to control participants, 100 SARS-CoV-2-related genes were increased in DGE (FDR<0.05) vs 13 genes in FD; 71 of these 100 genes were differentially expressed in DGE vs FD but only 3 between DGE patients with normal vs delayed GE. Upregulated genes in DGE include the SARS-CoV2 viral entry genes CTSL (|(Fold change) |=1.16; FDR<0.05) and CTSB (|Fold Change|=1.24; FDR<0.05) and selected genes involved in viral replication (eg, EIF2 pathways) and inflammation (CCR2, CXCL2, and LCN2, but not other inflammation-related pathways eg, IL-2 and IL-6 signaling).
Conclusions: Several SARS-CoV-2-related genes were differentially expressed between DGE vs healthy controls and vs FD but not between DGE patients with normal vs delayed GE, which suggests that the differential expression is related to diabetes per se. The upregulation of CTSL and CTSB and replication genes may predispose to SARS-CoV2 infection of the gastrointestinal tract in diabetes.

Keywords: coagulation; coronavirus; diabetes mellitus; idiopathic gastroparesis; vomiting.
 
Back
Top Bottom